Breaking News, Collaborations & Alliances

Wheeler Bio Partners with Mitsubishi to Expand Asia Pacific Business Development

As Wheeler's exclusive commercialization partner in the region, Mitsubishi will support the recruitment of new client relationships.

Author Image

By: Charlie Sternberg

Associate Editor

Wheeler Bio, a U.S.-based contract development and biomanufacturing organization (CDMO), has partnered with Mitsubishi Corporation to expand its commercial reach and business development activities across the Asia-Pacific region. Under this partnership, in addition to investing in Wheeler’s Series A-1 financing, Mitsubishi Corporation will leverage its regional network, industry relationships, and commercial expertise to identify and engage Asia-Pacific biotech innovators in Japan, Sout...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters